Double Blind, Placebo-Controlled, Randomised Investigation of Ondansetron in Schizophrenia
NCT01121042
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
85
Enrollment
OTHER_GOV
Sponsor class
Conditions
Schizoaffective and Schizophreniform Disorders
Schizophrenia
Interventions
DRUG:
Ondansetron
DRUG:
Placebo
Sponsor
Bayside Health